PUBLISHER: The Insight Partners | PRODUCT CODE: 1375087
PUBLISHER: The Insight Partners | PRODUCT CODE: 1375087
The South & Central America cardiac microcatheter market is expected to grow from US$ 22.69 million in 2023 to US$ 30.42 million by 2028. It is estimated to record a CAGR of 6.0% from 2023 to 2028.
Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO) Fuels South & Central America Cardiac Microcatheter Market Growth
Percutaneous coronary intervention (PCI) is one of the most difficult procedures for treating of chronic total occlusions (CTO), resulting in successful recanalization of CTO. Further, CTO is complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. Significant progress has been made in this area over the past decade, given the novel product launches and approvals. However, the launch of new technical devices and strategic refinements are still being monitored in the procedures to combat CTOs as the microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and CTO. Terumo's FineCross MG microcatheter integrates cross ability and guidewire support for treating challenging cases including tortuous vessels, CTOs, bifurcations, as well as severely stenosed and calcified lesions. Therefore, the growing usage of PCIs for treating CTO is catalyzing the cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Overview
The South & Central America cardiac microcatheter market is segmented into Argentina, Brazil, and the Rest of South & Central America. The region occupies a significant position in the South & Central America cardiac microcatheter market and is expected to record a promising growth rate during the forecast period. Drivers such as increase in prevalence of cardiovascular disease, rise in government initiatives, and upsurge in launches and approvals of products in the region are accelerating the South & Central America cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Cardiac Microcatheter Market Segmentation
The South & Central America cardiac microcatheter market is segmented into indication, end user, and country.
Based on indication, the South & Central America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the South & Central America cardiac microcatheter market in 2023.
Based on end user, the South & Central America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the South & Central America cardiac microcatheter market in 2023.
Based on country, the South & Central America cardiac microcatheter market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America cardiac microcatheter market in 2023.
Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; and Teleflex Inc are the leading companies operating in the South & Central America cardiac microcatheter market.